Delivering routine immunisations in London during the COVID-19 pandemic: lessons for future vaccine delivery. A mixed-methods study.
COVID-19
COVID-19 vaccines
general practice
health services
immunisation
primary health care
Journal
BJGP open
ISSN: 2398-3795
Titre abrégé: BJGP Open
Pays: England
ID NLM: 101713531
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
16
02
2021
accepted:
18
03
2021
pubmed:
20
5
2021
medline:
20
5
2021
entrez:
19
5
2021
Statut:
epublish
Résumé
General practices in England have continued to care for patients throughout the COVID-19 pandemic by instigating major changes to service delivery. Immunisations have continued, although the number of vaccines delivered initially dropped in April 2020. To evaluate how COVID-19 impacted the delivery of immunisations in London and identify innovative practices to inform future delivery, including for COVID-19 vaccines. A mixed-methods study of immunisation delivery in London, UK. An online survey of London general practices was undertaken in May 2020 to produce a descriptive analysis of childhood immunisation delivery and identify innovative delivery models. Semi-structured interviews were conducted between August and November 2020 to explore innovative immunisation models, which were analysed thematically. Sixty-eight per cent ( Immunisations continued during 2020 with practices adapting existing services. New delivery models were developed by building on existing local knowledge, experiences, and networks. Immunisation delivery during the pandemic, including for COVID-19 vaccines, should be tailored to local population needs by building on primary care immunisation expertise.
Sections du résumé
BACKGROUND
BACKGROUND
General practices in England have continued to care for patients throughout the COVID-19 pandemic by instigating major changes to service delivery. Immunisations have continued, although the number of vaccines delivered initially dropped in April 2020.
AIM
OBJECTIVE
To evaluate how COVID-19 impacted the delivery of immunisations in London and identify innovative practices to inform future delivery, including for COVID-19 vaccines.
DESIGN & SETTING
METHODS
A mixed-methods study of immunisation delivery in London, UK.
METHOD
METHODS
An online survey of London general practices was undertaken in May 2020 to produce a descriptive analysis of childhood immunisation delivery and identify innovative delivery models. Semi-structured interviews were conducted between August and November 2020 to explore innovative immunisation models, which were analysed thematically.
RESULTS
RESULTS
Sixty-eight per cent (
CONCLUSION
CONCLUSIONS
Immunisations continued during 2020 with practices adapting existing services. New delivery models were developed by building on existing local knowledge, experiences, and networks. Immunisation delivery during the pandemic, including for COVID-19 vaccines, should be tailored to local population needs by building on primary care immunisation expertise.
Identifiants
pubmed: 34006529
pii: BJGPO.2021.0021
doi: 10.3399/BJGPO.2021.0021
pmc: PMC8450879
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2021, The Authors.
Références
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Vaccines (Basel). 2020 Sep 22;8(3):
pubmed: 32972015
Ann Fam Med. 2020 Jul;18(4):349-354
pubmed: 32661037
BMJ Open. 2020 Jun 17;10(6):e039674
pubmed: 32554730
J Epidemiol Community Health. 2017 Jun;71(6):544-549
pubmed: 27531844
Pediatrics. 2020 Dec;146(6):
pubmed: 32999011
Lancet Infect Dis. 2021 Apr;21(4):459-460
pubmed: 33460565
PLoS One. 2010 Apr 16;5(4):e10199
pubmed: 20421908
Aust N Z J Public Health. 2012 Apr;36(2):106-8
pubmed: 22487341
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593
pubmed: 32407298
BMC Public Health. 2011 Jan 12;11:30
pubmed: 21226919
BMC Pediatr. 2012 Sep 21;12:154
pubmed: 22998654
Lancet Infect Dis. 2020 May;20(5):546
pubmed: 32311326
BMJ. 2020 Jun 16;369:m2392
pubmed: 32546575
J Investig Med. 2006 Sep;54(6):334-41
pubmed: 17134617
BMJ. 2020 Nov 30;371:m4654
pubmed: 33257346
PLoS One. 2020 Dec 28;15(12):e0244049
pubmed: 33370323
Euro Surveill. 2020 May;25(19):
pubmed: 32431288
J Gen Intern Med. 2014 Dec;29(12):1624-30
pubmed: 25155638
Vaccine. 2011 Jan 10;29(3):370-7
pubmed: 21075164
Nat Rev Immunol. 2020 Aug;20(8):449-450
pubmed: 32616908
J R Soc Med. 2020 Jun;113(6):208-210
pubmed: 32521196
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Vaccine. 2009 Dec 10;28(1):207-27
pubmed: 19800997